05/05/2016 17:54:18 1-888-992-3836 (toll free) Free Membership Login

Mylan N.V. News (NASDAQ:MYL)

DateTimeSource
Headline
05/05/20167:30AMPRNUSMylan Launches Generic Apresoline® Injection
Mylan Launches Generic Apresoline® Injection PR Newswire HERTFORDSHIRE, England and PITTSBURGH, May 5, 2016 HERTFORDSHIRE, England and PITTSBURGH, May 5, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced the U.S. launch of Hydralazine Hydrochloride Injection USP, 20 mg/mL, which is a generic version... More...>>
05/04/20168:01AMPRNUSSarah Jessica Parker Shares Her Personal Experience with Potentially Life-Threatening (Severe) Allergies through Mylan's Anap...
Sarah Jessica Parker Shares Her Personal Experience with Potentially Life-Threatening (Severe) Allergies through Mylan's Anaphylaxis: For Reel™ Initiative Parker, Mother of a Son with Severe Allergies, Will Join Leading Advocacy Organizations and Mylan to Call on Young Filmmakers and Families to Raise Awareness PR Newswire... More...>>
05/04/20167:30AMPRNUSMylan to Present at the Bank of America Merrill Lynch 19th Annual Health Care Conference
Mylan to Present at the Bank of America Merrill Lynch 19th Annual Health Care Conference PR Newswire HERTFORDSHIRE, England and PITTSBURGH, May 4, 2016 HERTFORDSHIRE, England and PITTSBURGH, May 4, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced that the Company will present at the Bank of America Merrill... More...>>
05/03/20169:37AMDJNU.S. Hot Stocks: Hot Stocks to Watch
Among the companies with shares expected to trade actively in Tuesday's session are Mallinckrodt PLC (MNK), Mylan NV (MYL) and Pfizer Inc. (PFE). Mallinckrodt PLC raised its profit forecast for the year as the biopharmaceutical company reported better-than-expected revenue and earnings in its latest quarter. Shares... More...>>
05/03/20167:50AMDJNMylan Posts Better-Than-Expected Profit
Mylan NV reported that its profit slipped in the latest quarter as expenses ticked up, though the pharmaceutical company's adjusted profit came in above analysts' projections. Shares of Mylan rose 5.3% to $44.97 a share in premarket trading. Heather Bresch, Mylan's chief executive, sought to quell concerns... More...>>
05/03/20167:30AMPRNUSMylan Names Kenneth Parks Chief Financial Officer
Mylan Names Kenneth Parks Chief Financial Officer PR Newswire HERTFORDSHIRE, England and PITTSBURGH, May 3, 2016 HERTFORDSHIRE, England and PITTSBURGH, May 3, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced the appointment of Kenneth S. Parks as chief financial officer, effective June 6, 2016.  Parks... More...>>
05/03/20162:30AMPRNUSMylan Reports Strong First Quarter 2016 Earnings Results Including Total Revenues Up 17%
Mylan Reports Strong First Quarter 2016 Earnings Results Including Total Revenues Up 17% PR Newswire HERTFORDSHIRE, England and PITTSBURGH, May 3, 2016 HERTFORDSHIRE, England and PITTSBURGH, May 3, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced its financial results for the quarter ended March 31... More...>>
04/19/20168:00AMPRNUSMylan to Report First Quarter 2016 Financial Results on May 3, 2016
Mylan to Report First Quarter 2016 Financial Results on May 3, 2016 PR Newswire HERTFORDSHIRE, England, and PITTSBURGH, April 19, 2016 HERTFORDSHIRE, England, and PITTSBURGH, April 19, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced that it will host a conference call and live webcast, on Tuesday... More...>>
04/11/20167:00AMPRNUSMylan Launches First and Only Available Intermediate Dosage Strengths of Generic Lopressor® Tablets 37.5 mg and 75 mg
Mylan Launches First and Only Available Intermediate Dosage Strengths of Generic Lopressor® Tablets 37.5 mg and 75 mg PR Newswire HERTFORDSHIRE, England and PITTSBURGH, April 11, 2016 HERTFORDSHIRE, England and PITTSBURGH, April 11, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced the U.S. launch of... More...>>
04/06/201611:14AMPRNUSMylan Launches Generic Epivir® Tablets
Mylan Launches Generic Epivir® Tablets PR Newswire HERTFORDSHIRE, England and PITTSBURGH, April 6, 2016 HERTFORDSHIRE, England and PITTSBURGH, April 6, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced the U.S. launch of Lamivudine Tablets USP, 150 mg and 300 mg, which is the generic version of ViiV... More...>>
03/28/20161:31PMPRNUSMylan Launches Generic Ultram® Extended-Release Tablets
Mylan Launches Generic Ultram® Extended-Release Tablets PR Newswire HERTFORDSHIRE, England and PITTSBURGH, March 28, 2016 HERTFORDSHIRE, England and PITTSBURGH, March 28, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced the U.S. launch of Tramadol Hydrochloride Extended-release Tablets USP, 100 mg... More...>>
03/04/201610:30AMPRNUSMylan to Present at the Barclays Global Healthcare Conference
Mylan to Present at the Barclays Global Healthcare Conference PR Newswire HERTFORDSHIRE, England and PITTSBURGH, March 4, 2016 HERTFORDSHIRE, England and PITTSBURGH, March 4, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced that the Company will present at the Barclays Global Healthcare Conference on... More...>>
03/04/201610:00AMPRNUSMylan to Present at the Raymond James 37th Annual Institutional Investors Conference
Mylan to Present at the Raymond James 37th Annual Institutional Investors Conference PR Newswire HERTFORDSHIRE, England and PITTSBURGH, March 4, 2016 HERTFORDSHIRE, England and PITTSBURGH, March 4, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced that the Company will present at the Raymond James 37th... More...>>
02/22/20167:16PMPRNUSMylan CEO Heather Bresch Elected Chair of Generic Pharmaceutical Association
Mylan CEO Heather Bresch Elected Chair of Generic Pharmaceutical Association PR Newswire HERTFORDSHIRE, England and PITTSBURGH, Feb. 22, 2016 HERTFORDSHIRE, England and PITTSBURGH, Feb. 22, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced that Mylan CEO Heather Bresch has been elected to serve as chair... More...>>
02/22/20168:00AMPRNUSMylan Appoints Anthony Mauro Chief Commercial Officer
Mylan Appoints Anthony Mauro Chief Commercial Officer Responsibility for driving global sales excellence throughout Mylan's global commercial operations PR Newswire HERTFORDSHIRE, England and PITTSBURGH, Feb. 22, 2016 HERTFORDSHIRE, England and PITTSBURGH, Feb. 22, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today... More...>>
02/19/201611:36AMPRNUSMylan's ANDA for Generic Advair Diskus® Accepted for Filing by FDA
Mylan's ANDA for Generic Advair Diskus® Accepted for Filing by FDA FDA Provides GDUFA Goal Date of March 28, 2017 PR Newswire HERTFORDSHIRE, England, and PITTSBURGH, Feb. 19, 2016 HERTFORDSHIRE, England, and PITTSBURGH, Feb. 19, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced that its abbreviated... More...>>
02/18/20168:40AMDJNPerrigo Swings to a Loss, Pulls in Full-Year Guidance
Perrigo Co. trimmed its 2016 earnings outlook after swinging to a loss in the fourth quarter, dragged by legal fees and a disappointing performance in its new branded consumer health-care segment. Shares slid 5.2% to $137.68 in premarket trading. The Dublin-based company, principally a maker of store-brand versions of... More...>>
02/16/20168:39AMPRNUSMylan Files Annual Report on Form 10-K for Year Ended Dec. 31, 2015
Mylan Files Annual Report on Form 10-K for Year Ended Dec. 31, 2015 PR Newswire HERTFORDSHIRE, England and PITTSBURGH, Feb. 16, 2016 HERTFORDSHIRE, England and PITTSBURGH, Feb. 16, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced that it filed its Annual Report on Form 10-K for the year ended December... More...>>
02/11/20169:42AMDJNU.S. Hot Stocks: Hot Stocks to Watch
Among the companies with shares expected to trade actively in Thursday's session are TripAdvisor Inc. (TRIP), Teva Pharmaceuticals Industries Ltd. (TEVA) and PepsiCo Inc. (PEP). TripAdvisor Inc. on Thursday reported a core profit that beat Wall Street expectations for the first time since 2013, as higher display advertising... More...>>
02/11/20168:50AMDJNTeva Pharmaceuticals Reports Sales Decline
Teva Pharmaceuticals Industries Ltd. reported a decline in revenue as drug sales fell across its generic and specialty segments. The company also released projections for the current quarter, saying it expects adjusted earnings in the range of $1.16 to $1.20 and revenue of $4.7 billion to $4.9 billion. When the impacts... More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:33 V:us D:20160505 21:54:19